Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays.
about
Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performanceResults of the Abbott RealTime HIV-1 assay for specimens yielding "target not detected" results by the Cobas AmpliPrep/Cobas TaqMan HIV-1 TestCorrection of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assayCost ramifications of increased reporting of detectable plasma HIV-1 RNA levels by the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 version 1.0 viral load test.Technical and regulatory shortcomings of the TaqMan version 1 HIV viral load assayComparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from GreeceCobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study.Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays.SWIFT: prospective 48-week study to evaluate efficacy and safety of switching to emtricitabine/tenofovir from lamivudine/abacavir in virologically suppressed HIV-1 infected patients on a boosted protease inhibitor containing antiretroviral regimen.Single-point mutations causing more than 100-fold underestimation of human immunodeficiency virus type 1 (HIV-1) load with the Cobas TaqMan HIV-1 real-time PCR assay.Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes.Comparison of the Abbott Realtime HIV-1 and HCV viral load assays with commercial competitor assays.Concordance of HIV-1 RNA Values by Amplicor and TaqMan 2.0 in Patients With Confirmed Suppression in Clinical TrialsEvaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENIn-house HIV-1 RNA real-time RT-PCR assays: principle, available tests and usefulness in developing countries.Evaluation of the Upgraded Version 2.0 of the Roche COBAS® AmpliPrep/COBAS® TaqMan HIV-1 Qualitative Assay in Central African Children.Clinical and resistance consequences of misquantification of plasma and cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) RNA in samples from an HIV-1 subtype G-infected patient.Comparative performances of HIV-1 RNA load assays at low viral load levels: results of an international collaboration.Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany.Causes and consequences of incomplete HIV RNA suppression in clinical trials.Defining treatment failure in resource-rich settings.Diagnosing acute HIV infection.Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1.Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification.Sequence conservation of the region targeted by the Abbott RealTime HBV viral load assay in clinical specimens.Performance of three commercial viral load assays, Versant human immunodeficiency virus type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants.HIV-1 load comparison using four commercial real-time assaysThe effect of valacyclovir on HIV and HSV-2 in HIV-infected persons on antiretroviral therapy with previously unrecognised HSV-2.Plasma load discrepancies between the Roche Cobas Amplicor human immunodeficiency virus type 1 (HIV-1) Monitor version 1.5 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 assays.Comparison of the Abbott realtime human immunodeficiency virus type 1 (HIV-1) assay to the Cobas AmpliPrep/Cobas TaqMan HIV-1 test: workflow, reliability, and direct costs.Comparison of the COBAS/Ampliprep Taqman and Amplicor HIV-1 monitor tests in Lagos, Nigeria.A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays.Reduction of the risk of transfusion-transmitted human immunodeficiency virus (HIV) infection by using an HIV antigen/antibody combination assay in blood donation screening in Cameroon.The significance of low-level plasma HIV viral load on COBAS TaqMan HIV-1 assays for patients with undetectable plasma viral load on COBAS Amplicor monitor version 1.5.
P2860
Q28286100-E7E33108-AC0E-4473-945A-1A1E7A036FF5Q33704727-276068E4-0AF5-4308-82CF-696E56C97647Q33769491-02E86BA7-D013-44A1-A0C5-820BCAAE6DD1Q33984137-00BEBEF7-C5DA-4B5A-A410-B38162C1340EQ34399511-2802CFCA-5482-4A50-B15A-3564B31C8532Q34547246-BCBE3826-14F0-4117-B666-911F3203978AQ34983777-BB1C1831-5A15-4F6C-B001-B568DDFE4808Q35273824-69CA2BD8-5852-434B-A980-66889B77C5BDQ35356381-CF65F56A-249C-4F04-B2BF-D12BFB51671EQ36811227-7CAD9885-7C53-4C3B-962A-6A2143BA9465Q37156958-4A384883-C3CB-4653-9587-81633C85C90BQ37191559-3595F4D4-A9DF-47BA-A431-9933F314ACAAQ37206232-3F8542E2-573D-4350-99D6-C1A58381B0ADQ37221125-7E9A9033-4E74-4560-8435-C5BF16D9BAD4Q37256264-FEF7122F-58C7-414A-A44F-C022A9B9D5A7Q37266495-359D0C1A-1902-4061-B39F-EB5BBE5FDA6AQ37387517-4AB09D25-6FEB-4E76-B9C6-7EDEAA49A6E5Q37410496-97C57F9B-4490-48B3-9B0E-9A5E070ED9ABQ37546182-2663CC6B-02B8-465C-9270-AFEAFAB8AB52Q37630304-29CC7801-676D-4E5B-9A03-F4DE3D80E027Q37631282-8487C171-324B-4384-B03B-8634C0C710D9Q37667776-8CC6AD83-FBC5-42CB-987A-8DA33736720EQ37965692-1FE337F4-F20B-48C5-BFD8-D546DF22A410Q38088726-5DC30B7C-FD0D-4067-84A8-1711569DCEB4Q38417936-615AAA3D-5D36-46A6-9E39-36A223138EC5Q41158571-205AE496-6095-4DE1-9244-9DA72EB187F9Q41961412-7C4AD275-F2F1-4B9A-870C-4232F4DA6E4CQ42113208-3C33D7B4-32D7-4AD1-85D4-318EE1896628Q42198575-13B4814E-6E73-4166-8287-13B67BBF4CEEQ43029344-EAAF0CE8-8B33-4AD0-9695-B142208FF5EEQ43146564-A5DBD25B-2BBC-43FF-8BC9-788D7739C4CCQ45045900-0C06E8DD-DC7A-4D53-8325-6B67271EBE10Q45371172-20A8BCC6-6B33-43C2-92F8-AC17789F7251Q45374189-8B2C7872-083B-4F38-A2BB-349F9BD0777AQ54518310-8CD50DEC-B87A-469C-B8F0-B1B83A269912
P2860
Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Human immunodeficiency virus t ...... rep/COBAS TaqMan HIV-1 assays.
@en
type
label
Human immunodeficiency virus t ...... rep/COBAS TaqMan HIV-1 assays.
@en
prefLabel
Human immunodeficiency virus t ...... rep/COBAS TaqMan HIV-1 assays.
@en
P2093
P2860
P356
P1476
Human immunodeficiency virus t ...... rep/COBAS TaqMan HIV-1 assays.
@en
P2093
B Roquebert
D Descamps
F Brun-Vezinet
P2860
P304
P356
10.1128/JCM.00973-07
P407
P577
2007-08-22T00:00:00Z